Sun Life Financial’s proposed $213.5 million settlement over legacy MetLife universal life policies is not just a large payout – it is a marker of how Canadian courts and carriers are dealing with long‑tail liability from interest‑sensitive products sold decades ago.
The agreement in principle, announced April 30, 2026, would resolve a certified national class action in Ontario concerning roughly 230,000 policies sold between the mid‑1980s and late 1990s and later inherited by Sun Life through Clarica.
According to a report from Money Canada, the action was filed in 2010 against Sun Life as successor to MetLife’s Canadian business and was certified in 2020. It focuses on three universal life products – Universal Plus, Flexiplus and Optimet – marketed when interest rates were high and later hit by a prolonged low‑rate environment.
The plaintiffs originally advanced a broad suite of claims, including misrepresentation, breach of contract and breach of duties of good faith and fair dealing in the sale and administration of the policies, and initially sought around $2.5 billion in damages. Over time, the case was narrowed, with courts finding that allegations tied to what individual agents said at the point of sale were too fact‑specific for class treatment. What remains at the heart of the settlement is how Sun Life, as administrator, interpreted the policy wording and applied cost‑of‑insurance and administrative fee increases across the book.
The case underscores how universal life designs that relied heavily on investment performance and flexible charges can generate litigation years later when credited rates fall and internal costs rise, particularly where contract language on pricing discretion is open to challenge.
Under the settlement in principle, Sun Life would make up to $213.5 million available to eligible policyholders, subject to court approval. The insurer expects the deal to translate into an after‑tax charge of about $145 million in its first‑quarter 2026 results.
Sun Life has emphasized that the dispute “does not involve any policies or products sold by Sun Life” under its own brand; the company took over administration of the contracts when it acquired Clarica in 2002, after Clarica had previously bought MetLife’s Canadian operations in 1998.
Behind the scenes, a second legal track is running. The report said MetLife provided an indemnity to Sun Life in respect of these policies, and Sun Life has said it will seek full recourse from MetLife if the settlement is approved. That separate, contract‑based recovery process will determine how much of the ultimate cost is borne by the acquirer versus the original writer, highlighting how M&A agreements can shift legacy product risk long after a transaction closes.
For insurers, the Sun Life-MetLife case is a reminder that contract wording on cost‑of‑insurance and policy charges can create long‑term exposure. Ambiguities in how and when insurers can adjust charges are a recurring theme in class actions involving universal life and other interest‑sensitive products.
The Canadian case sits alongside US litigation over cost‑of‑insurance increases at several carriers, pointing to a broader North American pattern, the report said.
The dispute also illustrates successor liability risk. Sun Life neither designed nor sold the original policies, but as the current administrator it became the defendant of record. Even where indemnities exist, acquirers can find themselves at the centre of class litigation, with capital and reputation on the line until cost‑sharing with the seller is resolved.
Rate‑environment shifts are another key backdrop. Products that looked sustainable in a high‑rate era have come under pressure in a long low‑rate cycle. Courts are being asked to decide whether later cost‑of‑insurance and fee changes were within the scope of contractual discretion or amounted to overreach.
The way the case has been narrowed is also instructive. The courts’ reluctance to certify broad misrepresentation claims on a class basis reflects the individualized nature of sales conversations and reliance. That does not remove exposure to individual suits or regulatory scrutiny, but it does signal that contract‑based theories around uniform charges and policy terms may be more suitable for class treatment than sales‑practice claims.
The proposed settlement lands in a market where regulators and rating agencies remain focused on legacy blocks and conduct risk. Sun Life’s move to crystallize exposure on this book, rather than continue to litigate common issues, comes as the company maintains strong capital ratios and ratings, and after OSFI’s implementation of IFRS 17 and related LICAT changes that sharpen the focus on managing long‑duration liabilities.
On the M&A side, the prominence of the indemnity arrangement with MetLife underscores the importance of due diligence on historical product design, pricing assumptions and complaint history when acquiring closed books or legacy lines. Buyers will be expected to negotiate robust protections – and to plan for the possibility that, even with those protections, they may be the public face of any future litigation tied to inherited products.
Whatever the final approval terms, the proposed settlement would effectively close one of Canada’s longest‑running life insurance class actions, while keeping the spotlight on how the industry manages legacy universal life risk in a changing rate and regulatory environment.
